Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 589724, 9 pages
http://dx.doi.org/10.1093/ecam/nep209
Original Article

A Clinical Trial of Kampo Formulae for the Treatment of Symptoms of Yusho, a Poisoning Caused by Dioxins and Related Organochlorine Compounds

1Research and Clinical Center for Yusho and Dioxin, Kyushu University Hospital, Fukuoka 812-8582, Japan
2Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Japan
3Department of Medical Informatics, Kyushu University Hospital, Japan
4Research Institute for Diseases of the Chest, Kyushu University Hospital, Japan
5Fukuoka Institute of Health and Environmental Sciences, Fukuoka, Japan

Received 29 January 2009; Accepted 12 November 2009

Copyright © 2011 Hiroshi Uchi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Kuratsune, T. Yoshimura, J. Matsuzaka, and A. Yamaguchi, “Epidemiologic study on Yusho, a poisoning caused by ingestion of rice oil contaminated with a commercial brand of polychlorinated biphenyls,” Environmental Health Perspectives, vol. 1, pp. 119–128, 1972. View at Google Scholar
  2. J. Nagayama, M. Kuratsune, and Y. Masuda, “Determination of chlorinated dibenzofurans in Kanechlors and “Yusho Oil”,” Bulletin of Environmental Contamination and Toxicology, vol. 15, no. 1, pp. 9–13, 1976. View at Google Scholar · View at Scopus
  3. L. R. Kamps, W. J. Trotter, S. J. Young et al., “Polychlorinated quarterphenyls identified in rice oil associated with Japanese “yusho” poisoning,” Bulletin of Environmental Contamination and Toxicology, vol. 20, pp. 589–591, 1978. View at Google Scholar
  4. M. Kuratsune, T. Yoshimura, J. Matsuzaka, and A. Yamaguchi, “Yusho, a poisoning caused by rice oil contaminated with polychlorinated biphenyls,” HSMHA Health Reports, vol. 86, no. 12, pp. 1083–1091, 1971. View at Google Scholar · View at Scopus
  5. T. Todaka, H. Hirakawa, T. Hori, K. Tobiishi, T. Iida, and M. Furue, “Concentrations of polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans, and non-ortho and mono-ortho polychlorinated biphenyls in blood of Yusho patients,” Chemosphere, vol. 66, pp. 1983–1989, 2007. View at Google Scholar
  6. T. Imamura, Y. Kanagawa, S. Matsumoto et al., “Relationship between clinical features and blood levels of pentachlorodibenzofuran in patients with Yusho,” Environmental Toxicology, vol. 22, pp. 124–131, 2007. View at Google Scholar
  7. Y. Kanagawa, S. Matsumoto, S. Koike et al., “Association of clinical findings in Yusho patients with serum concentrations of polychlorinated biphenyls, polychlorinated quarterphenyls and 2,3,4,7,8-pentachlorodibenzofuran more than 30 years after the poisoning event,” Environmental Health, vol. 7, p. 47, 2008. View at Google Scholar
  8. T. Imamura, S. Matsumoto, M. Akahane et al., “Cutaneous symptoms such as acneform eruption and pigmentation are closely associated with blood levels of 2,3,4,7,8-penta-chlorodibenzofurans in Yusho patients, using data mining analysis,” BMC Research Notes, vol. 2, article 27, 2009. View at Google Scholar
  9. H. Kobayashi, K. Takahashi, N. Muzuno, H. Kutsuna, and M. Ishii, “An alternative approach to atopic dermatitis: part II—summary of cases and discussion,” Evidence-Based Complementary and Alternative Medicine, vol. 1, pp. 145–155, 2004. View at Google Scholar
  10. H. Kobayashi, M. Ishii, S. Takeuchi et al., “Efficacy and safety of a traditional herbal medicine, Hochu-ekki-to in the long-term management of Kikyo (delicate constitution) patients with atopic dermatitis: a 6-month, multicenter, double-blind, randomized, placebo-controlled study,” Evidence-Based Complementary and Alternative Medicine, vol. 7, no. 3, pp. 367–373, 2008. View at Google Scholar
  11. J. Kamei, R. Nakamura, H. Ichiki, and M. Kubo, “Antitussive principles of Glycyrrhizae radix, a main component of the Kampo preparations Bakumondo-to (Mai-men-dong-tang),” European Journal of Pharmacology, vol. 469, no. 1-3, pp. 159–163, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Saruwatari, S. Hisaeda, Y. Higa, Y. Tomiyasu, K. Nakagawa, and T. Ishizaki, “The in-vivo effect of bakumondo-to (TJ-29), a traditional Japanese medicine used for treatment of chronic airway disease, on cytochrome P450 1A2, xanthine oxidase and N-acetyltransferase 2 activity in man,” Journal of Pharmacy and Pharmacology, vol. 56, pp. 1171–1177, 2004. View at Google Scholar
  13. S. Higaki, Y. Hasegawa, M. Morohashi, and Y. Takayoshi, “The correlation of Kampo formulations and their ingredients on anti-bacterial activities against propionibacterium acnes,” Journal of Dermatology, vol. 22, no. 1, pp. 4–9, 1995. View at Google Scholar · View at Scopus
  14. S. Higaki, M. Nakamura, M. Morohashi, and T. Yamagishi, “Propionibacterium acnes biotypes and susceptibility to minocycline and Keigai-rengyo-to,” International Journal of Dermatology, vol. 43, no. 2, pp. 103–107, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Nishizawa, W. H. F. Sutherland, and H. Nukada, “Gosha-jinki-gan (herbal medicine) in streptozocin-induced diabetic neuropathy,” Journal of the Neurological Sciences, vol. 132, no. 2, pp. 177–181, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Fukuhara, J. E. Ware Jr., M. Kosinski, S. Wada, and B. Gandek, “Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey,” Journal of Clinical Epidemiology, vol. 51, no. 11, pp. 1045–1053, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Yoshimura, H. Kamimura, K. Oguri, Y. Honda, and M. Nakano, “Stimulating effect of activated charcoal beads on fecal excretion of 2,3,4,7,8-pentachlorodibenzofuran in rats,” Chemosphere, vol. 15, pp. 219–227, 1986. View at Google Scholar
  18. K. Oguri, H. Kamimura, N. Koga, and H. Yoshimura, “Mechanisms for stimulated fecal excretion of 2,3,4,7,8-pentachlorodibenzofuran in rats by treatment with squalane and liquid paraffin,” Chemosphere, vol. 16, pp. 1707–1712, 1987. View at Google Scholar
  19. S. Takenaka, K. Morita, H. Tokiwa, and K. Takahashi, “Effects of rice bran fibre and cholestyramine on the faecal excretion of Kanechlor 600 (PCB) in rats,” Xenobiotica, vol. 21, no. 3, pp. 351–357, 1991. View at Google Scholar · View at Scopus
  20. T. Iida, R. Nakagawa, H. Hirakawa et al., “Clinical trial of a combination of rice bran fiber and cholestyramine for promotion of fecal excretion of retained polychlorinated dibenzofuran and polychlorinated biphenyl in Yu-cheng patients,” Fukuoka Acta Medica, vol. 86, pp. 226–233, 1995. View at Google Scholar
  21. J. Mimura and Y. Fujii-Kuriyama, “Functional role of AhR in the expression of toxic effects by TCDD,” Biochimica et Biophysica Acta, vol. 1619, no. 3, pp. 263–268, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. P. M. Fernandez-Salguero, D. M. Hilbert, S. Rudikoff, J. M. Ward, and F. J. Gonzalez, “Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity,” Toxicology and Applied Pharmacology, vol. 140, pp. 173–179, 1996. View at Google Scholar
  23. Y. Shimizu, Y. Nakatsuru, M. Ichinose et al., “Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 2, pp. 779–782, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. H. P. Ciolino, P. J. Daschner, and G. C. Yeh, “Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor,” Cancer Research, vol. 58, no. 24, pp. 5707–5712, 1998. View at Google Scholar · View at Scopus
  25. H. P. Ciolino, P. J. Daschner, T. T. Y. Wang, and G. C. Yeh, “Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells,” Biochemical Pharmacology, vol. 56, no. 2, pp. 197–206, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Amakura, T. Tsutsumi, K. Sasaki, T. Yoshida, and T. Maitani, “Screening of the inhibitory effect of vegetable constituents on the aryl hydrocarbon receptor-mediated activity induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin,” Biological and Pharmaceutical Bulletin, vol. 26, no. 12, pp. 1754–1760, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Amakura, T. Tsutsumi, K. Sasaki, M. Nakamura, T. Yoshida, and T. Maitani, “Influence of food polyphenols on aryl hydrocarbon receptor-signaling pathway estimated by in vitro bioassay,” Phytochemistry, vol. 69, no. 18, pp. 3117–3130, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Fukuda, R. Mukai, M. Kawase, K.-I. Yoshida, and H. Ashida, “Interaction between the aryl hydrocarbon receptor and its antagonists, flavonoids,” Biochemical and Biophysical Research Communications, vol. 359, no. 3, pp. 822–827, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. A. M. Tritscher, J. Mahler, C. J. Portier, G. W. Lucier, and N. J. Walker, “Induction of lung lesions in female rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin,” Toxicologic Pathology, vol. 28, no. 6, pp. 761–769, 2000. View at Google Scholar · View at Scopus
  30. Y. Nakanishi, N. Shigematsu, Y. Kurita et al., “Respiratory involvement and immune status in Yusho patients,” Environmental Health Perspectives, vol. 59, pp. 31–36, 1985. View at Google Scholar
  31. P. S. Wong, C. F. Vogel, K. Kokosinksi, and F. Matsumura, “Arylhydrocarbon receptor (AhR) activation in NCI-H441 cells and C57/BL6 mice; possible mechanisms for lung dysfunction,” American Journal of Respiratory Cell and Molecular Biology, vol. 42, pp. 210–217, 2009. View at Google Scholar